FN1 and carcinoma: Fibroblasts found in carcinomas appear to exhibit an altered phenotype characterized by the increased expression of α-smooth muscle actin (α-SMA) and fibroblast activation protein (FAP), as well as increased secretion of extracellular matrix proteins (ECM), including fibronectin and fibrous type I collagen [27,28].